Executive Change: Veracyte (NASDAQ: VCYT) Appoints Kevin Haas as Chief Development and Technology Officer
South San Francisco, CA – Veracyte Inc. has announced the appointment of Kevin Haas as Chief Development and Technology Officer. About Veracyte Inc.: Veracyte Inc. is a leader in cancer genomic testing and molecular diagnostics,…